VRNA Verona Pharma PLC Future Profit

Official company branding of Verona Pharma PLC (VRNA)

Verona Pharma plc (VRNA) is implementing advanced therapy methods for severe pulmonary pathologies, creating unique classes of medications. Business growth relies on partnerships with global industry behemoths to ensure the rapid launch of products. The current profit figure stands at 0.03, and the price action shown below highlights the risks associated with the approval of new drugs and the efficiency of their subsequent distribution.

veronapharma.com (VRNA): Expected Net Profit from 01/13/2025 to 10/18/2025

Verona Pharma Corp - analytical breakdowns and key metrics (VRNA)

- share price and consensus valuation forecast:
Fundamental company analysis:VRNA, Verona Pharma
Finished products of Verona Pharma PLC

The commercial launch of the innovative drug Ohtuvayre for the treatment of COPD transitions Verona Pharma plc (VRNA) into a phase of active revenue scaling. The estimated profit dynamics reflect a daily revaluation of expected earnings based on a mathematical balance of risks, allowing investors to identify hidden drawdowns in the business's margin of safety that may be masked by one-off trades from major players during exchange sessions.

Competitor analysis for Verona Pharma plc

Future Profit HLN|Projected Future Earnings Kenvue Corp|Future Profit MENS (Jyong Biotech Corp)|LGND (Ligand Corp) - Expected Net Income|Expected Profit Amneal Pharmaceuticals, Inc. AMRX|Perrigo (PRGO) - Expected Net Profit|ALVO: Future Profit|Liquidia - Future Net Profit|GLPG: Projected Future Earnings|ANI Pharma - Expected Net Income|MNKD (MannKind Corp) - Projected Future Earnings|Expected Net Profit amphastar.com AMPH|Expected Profit Pacira BioSciences, Inc. (PCRX)|SPRY (ARS Pharmaceuticals, Inc.) - Expected Net Income|Theravance Biopharma, Inc. - Future Profit|Projected Future Earnings Aquestive Corp AQST|scPharmaceuticals - Projected Future Earnings|Expected Net Profit tectonictx.com|Tonix Pharmaceuticals Inc. (TNXP) - Expected Profit|SXTC - Company Profit Forecast|Expected Profit eupraxiapharma.com|BHST: Expected Net Income|Future Profit EXOZ (Invizyne Technologies)|ORMP - Expected Net Profit|Projected Future Earnings ENTX (Entera Bio Ltd)|Projected Future Earnings MindWalk Holdings, Inc. HYFT|ABVC BioPharma, Inc - Projected Future Earnings|CPIX: Expected Profit|QNTM (Quantum BioPharma Ltd) - Future Profit|Net Profit Forecast FGEN|Expected Profit Telomir Pharmaceuticals|RANI: Expected Net Income|Projected Future Earnings SNYR|Future Profit Rallybio Corp RLYB|Expected Profit Lexaria Bioscience Corp. LEXX|Company Profit Forecast pulmatrix.com (PULM)|Pheton Holdings Limited - Projected Future Earnings|Forward Earnings APM|LYRA (Lyra Therapeutics Inc.) - Future Profit|IBO - Company Profit Forecast|Future Profit TNFA|Net Profit Forecast YCBD (cbdmd.com)|Future Profit PRFX (PainReform Ltd)|CYTO: Forward Earnings|Projected Future Earnings LIPO (lipella.com)|Future Net Profit OPTN (OptiNose Corp)|PIRS: Future Profit|PROC - Projected Future Earnings|PTPI: Projected Future Earnings|Qilian International Holding Group (QLI) - Projected Future Earnings|SLRN (ACELYRIN, Inc.) - Projected Future Earnings|TFF Pharmaceuticals (TFFP) - Company Profit Forecast